Press Release Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine Jun 18
Press Release Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028 Jun 16
Press Release Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome Jun 8